Kevin Chaplin
Kevin is responsible for overseeing Kardium’s operations, leading the executive team, and setting the company’s strategic direction, while also engaging with key external stakeholders. Kevin joined Kardium shortly after its founding, and has played a pivotal role in securing capital, building a premier investor syndicate, and leading the company through its successful FDA pivotal study. Under his leadership, Kardium has grown to a team of over 600 employees. Prior to leading Kardium as the CEO, Kevin held senior roles in product management, marketing and technical positions at Kodak, Sierra Wireless, and Accenture. He holds a BSc in Chemical Engineering from the University of Cape Town and is also an active board member of Life Sciences BC.
What about Kardium motivates Kevin? “It’s a once in a lifetime opportunity to do something revolutionary.”